$17.25
4.96[40.36%]
At close: Apr 24
$17.25
0[0.00%]
PreMarket: 7:59PM EDT
Cidara Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cidara Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | PM | CDTX | Q1 | $0.03 | -$0.07 | — | — | $25.99M | $14.50M | — | — | Get Alert |
04/22/2024 | PM | CDTX | Q4 | -$0.19 | -$0.10 | -$0.04 | 60.00% | $10.22M | $11.54M | $17.58M | 52.37% | Get Alert |
11/02/2023 | PM | CDTX | Q3 | $0.17 | -$0.16 | -$0.09 | 43.75% | $40.74M | $8.14M | $12.72M | 56.24% | Get Alert |
08/03/2023 | PM | CDTX | Q2 | -$0.19 | -$0.13 | -$0.14 | -7.69% | $6.22M | $11.55M | $7.61M | -34.08% | Get Alert |
05/11/2023 | PM | CDTX | Q1 | -$0.27 | $0.04 | $0.03 | -25.00% | $7.11M | $18.68M | $25.99M | 39.13% | Get Alert |
03/23/2023 | AM | CDTX | Q4 | -$0.26 | -$0.17 | -$0.19 | -11.76% | $7.22M | $10.57M | $10.22M | -3.32% | Get Alert |
11/03/2022 | PM | CDTX | Q3 | -$0.37 | $0.18 | $0.17 | -5.56% | $7.08M | $35.67M | $40.74M | 14.22% | Get Alert |
08/09/2022 | PM | CDTX | Q2 | $0.18 | -$0.28 | -$0.19 | 32.14% | $32.86M | $6.21M | $6.22M | 0.10% | Get Alert |
05/11/2022 | PM | CDTX | Q1 | -$0.39 | -$0.29 | -$0.27 | 6.90% | $2.41M | $6.11M | $7.11M | 16.35% | Get Alert |
03/07/2022 | PM | CDTX | Q4 | -$0.49 | -$0.34 | -$0.26 | 23.53% | $3.73M | $4.31M | $7.22M | 67.63% | Get Alert |
11/10/2021 | PM | CDTX | Q3 | -$0.41 | -$0.36 | -$0.37 | -2.78% | $2.42M | $2.94M | $7.08M | 140.68% | Get Alert |
08/12/2021 | PM | CDTX | Q2 | -$0.45 | -$0.08 | $0.18 | 325.00% | $3.39M | $18.20M | $32.86M | 80.57% | Get Alert |
05/13/2021 | PM | CDTX | Q1 | -$0.46 | -$0.31 | -$0.39 | -25.81% | $2.53M | $8.33M | $2.41M | -71.09% | Get Alert |
02/25/2021 | PM | CDTX | Q4 | -$0.42 | — | -$0.49 | — | $1.81M | — | $3.73M | — | Get Alert |
11/05/2020 | PM | CDTX | Q3 | $0.08 | — | -$0.41 | — | $19.10M | — | $2.42M | — | Get Alert |
08/13/2020 | PM | CDTX | Q2 | -$0.47 | — | -$0.45 | — | $0.00 | — | $3.39M | — | Get Alert |
05/13/2020 | PM | CDTX | Q1 | -$0.58 | — | -$0.46 | — | $0.00 | — | $2.53M | — | Get Alert |
03/04/2020 | AM | CDTX | Q4 | -$0.44 | -$0.43 | -$0.42 | 2.33% | $0.00 | $3.63M | $1.81M | -50.00% | Get Alert |
11/07/2019 | PM | CDTX | Q3 | -$0.49 | — | $0.08 | — | $0.00 | — | $19.10M | — | Get Alert |
Cidara Therapeutics (CDTX) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on April 22, 2024 for Q4.
The Actual EPS was $-0.04, which beat the estimate of $-0.10.
The Actual Revenue was $17.6M, which beat the estimate of $11.5M.
Browse earnings estimates, EPS, and revenue on all stocks.